Jacob Chacko's Net Worth
Jacob Chacko's net worth is estimated to be at least $4,166,353.41 as of 12/23/2024. CoreStreet's estimation of Jacob Chacko's net worth is based on their sale of stock and current holding of stock.
Jacob Chacko is CEO at Oric Pharmaceuticals Inc. They have executed at least 27 trades of stock as per SEC Form 4 filings. Their most recent trade was for 24,660 units of ORIC stock on 12/16/2024. Their biggest sale was on 12/16/2024 when they sold 24,660 units of Oric Pharmaceuticals Inc stock for $204,184.80. They typically trade 3 times per year.
Total value of insider buys:
- $2,703,858.38
Total value of insider sells:
- $1,462,495.03
Most recent insider trade:
- Dec. 16, 2024
Jacob Chacko's Insider Trading History
| Oric Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 16, 2024 | CEO | 24,660 | $8.28 | Sell | $204,184.80 |
Feb. 6, 2024 | CEO | 13,958 | $12.12 | Sell | $169,170.96 |
Dec. 15, 2023 | CEO | 14,539 | $8.58 | Sell | $124,744.62 |
July 10, 2023 | CEO | 10,508 | $8.01 | Sell | $84,169.08 |
July 5, 2023 | CEO | 4,336 | $8.01 | Sell | $34,731.36 |
June 26, 2023 | CEO | 20,000 | $8.03 | Sell | $160,600.00 |
Dec. 15, 2022 | CEO | 5,764 | $3.25 | Sell | $18,733.00 |
May 13, 2022 | CEO | 76,072 | $2.82 | Buy | $214,523.04 |
May 11, 2022 | CEO | 304,574 | $2.90 | Buy | $883,264.60 |
March 25, 2022 | CEO | 50,000 | $4.54 | Buy | $227,000.00 |
March 23, 2022 | CEO | 257,127 | $4.98 | Buy | $1,280,492.46 |
Sept. 15, 2021 | CEO | 3,736 | $25.06 | Sell | $93,624.16 |
Sept. 13, 2021 | CEO | 2,801 | $25.02 | Sell | $70,081.02 |
Sept. 10, 2021 | CEO | 2,942 | $25.08 | Sell | $73,785.36 |
Sept. 7, 2021 | CEO | 5,981 | $25.11 | Sell | $150,182.91 |
May 24, 2021 | CEO | 12 | $25.00 | Sell | $300.00 |
May 20, 2021 | CEO | 2,468 | $25.07 | Sell | $61,872.76 |
May 13, 2021 | CEO | 730 | $25.04 | Sell | $18,279.20 |
May 11, 2021 | CEO | 1,090 | $25.22 | Sell | $27,489.80 |
April 30, 2021 | CEO | 1,300 | $25.14 | Sell | $32,682.00 |
April 28, 2021 | CEO | 700 | $25.06 | Sell | $17,542.00 |
April 1, 2021 | CEO | 800 | $25.09 | Sell | $20,072.00 |
| 4D Molecular Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 21, 2023 | Director | 5,000 | $20.05 | Sell | $100,250.00 |
| Prometheus Biosciences Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 17, 2016 | CFO | 10,000 | $5.64 | Buy | $56,400.00 |
Dec. 16, 2015 | CFO | 1,500 | $12.00 | Buy | $18,000.00 |
Nov. 24, 2014 | CFO | 1,598 | $6.46 | Buy | $10,323.08 |
Aug. 19, 2014 | CFO | 1,840 | $7.53 | Buy | $13,855.20 |